CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis
Explore this paper's citation graph
Summary
A significant association between CD147/EMMPRIN overexpression and adverse tumor outcomes, such as overall survival, disease-specific survival, progression- free survival, metastasis-free survival or recurrence-free Survival, irrespective of the model analysis is found.
- Type
- review
- Published
- 2016-09-09
- Cited by
- 117
- References
- 74
- Access
- Open access
- OpenAlex
- https://openalex.org/W2514489125
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:17682960
Keywords
Medicine, Meta-analysis, Oncology, Tumor progression, Internal medicine
References
- Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
- Co-expression of CD147 and GLUT-1 indicates radiation resistance and poor prognosis in cervical squamous cell carcinoma.
- Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma.
- Publication Bias in Meta-Analysis: Prevention, Assessment and Adjustments
- Expression and clinical implications of HAb18G/CD147 in hepatocellular carcinoma
- Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas
- Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
- HAb18G (CD147), a cancer‐associated biomarker and its role in cancer detection
- Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis
- Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9
- CD147 in Ovarian and Other Cancers
- Expression of CD147 and Lewis y antigen in ovarian cancer and their relationship to drug resistance
- Expression of Matrix Metalloproteinase 2 and Extracellular Matrix Metalloproteinase Inducer are Unfavorable Postoperative Prognostic Factors in Intrahepatic Cholangiocarcinoma
- EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma
- Prediction of prognosis in gallbladder carcinoma by CD147 and MMP-2 immunohistochemistry
- ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma
- RNA interference targeting the CD147 induces apoptosis of multi-drug resistant cancer cells related to XIAP depletion.
- Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomas
- EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas
- Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas
Cited by
- Elevated CD147 expression is associated with shorter overall survival in non-small cell lung cancer
- CD147 and glioma: a meta-analysis
- CD147 as a novel biomarker for predicting the prognosis and clinicopathological features of bladder cancer: a meta-analysis
- CD147 expression was positively linked to aggressiveness and worse prognosis of gastric cancer: a meta and bioinformatics analysis
- CD147-mediated chemotaxis of CD4+CD161+ T cells may contribute to local inflammation in rheumatoid arthritis
- Breast cancer bone metastases: pathogenesis and therapeutic targets.
- The role of extracellular matrix metalloproteinase inducer glycosylation in regulating matrix metalloproteinases in periodontitis
- System analysis of the regulation of the immune response by CD147 and FOXC1 in cancer cell lines
- The Role of Exosomal Tetraspanins and Proteases in Tumor Progression
- Calprotectin (S100A8/S100A9): a key protein between inflammation and cancer
- CD147‐mediated glucose metabolic regulation contributes to the predictive role of 18F‐FDG PET/CT imaging for EGFR‐TKI treatment sensitivity in NSCLC
- Hold the door: hPMCA1/neuroplastin interactions regulate Ca2+-binding site accessibility
- Generation and Characterization of Fibroblast-Specific Basigin Knockout Mice
- Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma – MCT1 as potential target in diffuse large B cell lymphoma
- Structural insights on druggable hotspots in CD147: A bull's eye view.
- Proximity ligation assays for precise quantification of femtomolar proteins in single cells using self-priming microfluidic dPCR chip.
- Microbial carcinogenesis: Lactic acid bacteria in gastric cancer.
- Tumor Metabolism as a Regulator of Tumor–Host Interactions in the B-Cell Lymphoma Microenvironment—Fueling Progression and Novel Brakes for Therapy
- The role of basigin in reproduction.
- Peptidome profiles in melamine diet-induced bladder stones in C57BL/6 mice.
Related papers
- Changes of Serum Concentrations of Matrix Metalloproteinases,Tissue Inhibitors of Metalloproteinases and Type IV Collagen in patients with various types of glomerulonephritis(種々の糸球体腎炎患者におけるMatrix Metalloproteinases,Tissue Inhibitors of Metalloproteinases,IV型コラーゲンの血清中濃度の変化)
- Matrix Metalloproteinases(MMPs)and Tissue Inhibitors of Metalloproteinases(TIMPs)in the Development and Disease of Oral Tissues
- Progress in study of matrix metalloproteinases and tumour invasion and metastasis
- Effects of matrix metalloproteinase on the invasion and metastasis of antitumor
- MATRIX METALLOPROTEINASES AND METASTASIS OF LUNG CANCER
- Matrix metalloproteinases-2， -9 and tissue inhibitor of metalloproteinase-1 in lung cancer invasion and metastasis
- Research advance of matrix metalloproteinases with p53 and nuclear factor-kappaB in tumor invasion and metastasis
- Correlation of MMP and TIMP with osteosarcoma invasion and metastasis
- Matrix metalloproteinases: multifunctional contributors to tumor progression.
- The Role of Exosome-Derived microRNA on Lung Cancer Metastasis Progression